Humacyte, Inc. (HUMA) Tops Q4 EPS by 9c

Humacyte, Inc. (NASDAQ: HUMA) reported Q4 EPS of ($0.16), $0.09 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Stifel Starts Arrowhead Pharma (ARWR) at Buy
• DHT Holdings Q2 TCE earnings estimated at $126,700 per day
• Gyre Therapeutics (GYRE) files for 31.03M share offering by selling stockholders